Reduced production rates of testosterone and dihydrotestosterone in healthy men treated with rosiglitazone

Metabolism: Clinical and Experimental

Volumn 52, Issue 2, 2003, Pages 230-232

  Vierhapper, H ^a   Nowontny, P ^a   Waldhausl W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 6BETA HYDROXYHYDROCORTISONE; ALLOTETRAHYDROCORTISOL; ANDROSTANOLONE; ANDROSTERONE; ETIOCHOLANOLONE; GLUCOCORTICOID; GLUCOSE; HYDROCORTISONE; HYDROCORTISONE DERIVATIVE; LUTEINIZING HORMONE; PREGNANETRIOL; ROSIGLITAZONE; SEX HORMONE; STABLE ISOTOPE; STEROID; STEROID HORMONE; TESTOSTERONE; TESTOSTERONE DERIVATIVE; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCULATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DILUTION; GLUCOSE BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; HUMAN EXPERIMENT; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; STEROID URINE LEVEL; STEROIDOGENESIS; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0037302009     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2003.50028     Document Type: Article

References (20)

1. Henry RR: Thiazolidinediones. Metab Clin North Am 26:553-573, 1997
2. Olefsky JM: Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonist. J Clin Invest 106:467-472, 2000
3. Neuschwandner-Tetri BA, Isley WL, Old JC, et al: Troglitazone-induced hepatic failure leading to liver transplantation: A case report. Ann Intern Med 129:38-41, 1998
4. Gasic S, Badenburg Y, Nagamani M, et al: Troglitazone inhibits progesterone production in porcine granulosa cells. Endocrinology 139:4962-4966, 1998
5. Mu Y-M, Yanase T, Nishi Y, et al: Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells. Biochem Biophys Res Commun 271:710-713, 2000
6. Gasic S, Nagamani M, Green A, et al: Troglitazone is a competitive inhibitor of 3beta-hydroxysteroid dehydrogenase enzyme in the ovary. Am J Obstet Gynecol 184:575-579, 2001
7. Arlt W, Auchus RJ, Miller WL: Thaizolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3β-hydroxysteroid dehydrogenase. J Biol Chem 276:16767-16771, 2001
8. Fürnsinn C, Nowotny P, Brunmair B, et al: Thiazolidinediones influence plasma steroids of male obese zucker rats. Endocrinology 143:327-331, 2002
9. DeAvellar IGJ, Vierhapper FW: Novel partial synthetic approaches to replace carbons 2,3,4 of steroids. A methodology to label testosterone and progesterone with C-13 in the steroid A ring. Part 1. Tetrahedron 56:9957-9965, 2000
10. 13C in the steroid A ring. Part 2. Tetrahedron 56:9967-9974, 2000
11. Vierhapper H, Nowotny P, Waldhaeusl W: Stimulation of gonadal steroid synthesis by chronic excess of ACTH in patients with adrenocortical insufficiency. J Clin Invest 77:1063-1070, 1986
12. Vierhapper H, Nowotny P: The stress of being a doctor: Steroid excretion rates in internal medicine residents on and off duty. Am J Med 109:492-494, 2000
13. Vierhapper H, Nowotny P, Waldhäusl W: Sex-specific differences in cortisol production rates in humans. Metabolism 47:974-976, 1998.
14. Vierhapper H, Nowotny P, Waldhäusl W: Determination of testosterone production rates in men and women using stable isotope/dilution and mass spectrometry. J Clin Endocrinol Metab 82:1492-1496, 1997
15. Vierhapper H, Nowotny P, Maier H, et al: Production rates of dihydrotestosterone in healthy men and women and in men with male pattern baldness: Determination by stable isotope/dilution and mass spectrometry. J Clin Endocrinol Metab 86:5762-5764, 2001
16. Wootton R, Ford GC, Cheng KN, et al: Calculation of turnover rates in stable-isotope studies. Phys Med Biol 30:1143-1149, 1985
17. Loi CM, Stern R, Koup JR, et al: Effect of troglitazone on the pharmacokinetics of an oral contraceptive agent. J Clin Pharmacol 39:410-417, 1999
18. Morita H, Oki Y, Ito T, et al: Administration of troglitazone, but not pioglitazone, reduces insulin resistance caused by short-term dexamethasone (DXM) treatment by accelerating the metabolism of DXM. Diabetes Care 24:788-789, 2001
19. Koup JR, Anderson GD, Loi CM: Effect of troglitazone on urinary excretion of 6β-hydroxycortisol. J Clin Pharmacol 38:815-818, 1998
20. Berger J, Tanen M, Elbrecht A, et al: Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem 276:12629-12635, 2001